Unknown

Dataset Information

0

Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.


ABSTRACT: AIMS:Previous trials on the effectiveness of genotype-guided warfarin dosing vs. conventional dosing have been inconclusive. We conducted a systematic review and meta-analysis of randomized trials comparing genotype-guided to conventional dosing strategies. METHODS:PubMed and the Cochrane Library were searched up to 23 October 2017. RESULTS:A total of 76 and 94 entries were retrieved were retrieved from PubMed and the Cochrane Library, respectively. A total of 2626 subjects in the genotype-guided dosing (mean age 63.3 ± 5.8 years; 46% male) and 2604 subjects in the conventional dosing (mean age 64.7 ± 6.1 years; 46% male) groups (mean follow-up duration 64 days) from 18 trials were included. Compared with conventional dosing, genotype-guided dosing significantly shortened the time to first therapeutic international normalized ratio (INR) (mean difference 2.6 days, standard error 0.3 days; P < 0.0001; I2 0%) and time to first stable INR (mean difference 5.9 days, standard error 2.0 days; P < 0.01; I2 94%). Genotype-guided dosing also increased the time in therapeutic range (mean difference 3.1%, standard error 1.2%; P < 0.01; I2 80%) and reduced the risks of both excessive anticoagulation, defined as INR ≥4 [risk ratio (RR) 0.87; 95% confidence interval (CI) 0.78, 0.98; P < 0.05; I2 : 0%), and bleeding (RR 0.82; 95% CI 0.69, 0.98; P < 0.05; I2 31%). No difference in thromboembolism (RR 0.84; 95% CI 0.56, 1.26; P = 0.40; I2 0%) or mortality (RR 1.16; 95% CI 0.46, 2.91; P = 0.76; I2 0%) was observed between the two groups. CONCLUSIONS:Genotype-guided warfarin dosing offers better safety with less bleeding compared with conventional dosing strategies. No significant benefit on thromboembolism or mortality was evident.

SUBMITTER: Tse G 

PROVIDER: S-EPMC6089819 | biostudies-other | 2018 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.

Tse Gary G   Gong Mengqi M   Li Guangping G   Wong Sunny Hei SH   Wu William K K WKK   Wong Wing Tak WT   Roever Leonardo L   Lee Alex Pui Wai APW   Lip Gregory Y H GYH   Wong Martin C S MCS   Liu Tong T  

British journal of clinical pharmacology 20180621 9


<h4>Aims</h4>Previous trials on the effectiveness of genotype-guided warfarin dosing vs. conventional dosing have been inconclusive. We conducted a systematic review and meta-analysis of randomized trials comparing genotype-guided to conventional dosing strategies.<h4>Methods</h4>PubMed and the Cochrane Library were searched up to 23 October 2017.<h4>Results</h4>A total of 76 and 94 entries were retrieved were retrieved from PubMed and the Cochrane Library, respectively. A total of 2626 subjects  ...[more]

Similar Datasets

| S-EPMC4556123 | biostudies-literature
| S-EPMC4682655 | biostudies-literature
| S-EPMC7181853 | biostudies-literature
| S-EPMC6038204 | biostudies-literature
| S-EPMC7439928 | biostudies-literature
| S-EPMC10070678 | biostudies-literature
| S-EPMC5389380 | biostudies-literature
| S-EPMC5818817 | biostudies-literature
| S-EPMC1488863 | biostudies-other
| S-EPMC6419473 | biostudies-literature